Availability 0 12 0 12 O
of 13 15 13 15 O
tumor 16 21 16 21 B-cancer
tissue 22 28 22 28 O
at 29 31 29 31 O
study 32 37 32 37 O
enrollment 38 48 38 48 O

Body 0 4 49 53 B-clinical_variable
weight 5 11 54 60 I-clinical_variable
must 12 16 61 65 O
be 17 19 66 68 O
> 20 21 69 70 O
= 21 22 70 71 O
20 23 25 72 74 B-lower_bound
kilograms 26 35 75 84 I-lower_bound
( 36 37 85 86 I-lower_bound
kg 37 39 86 88 I-lower_bound
) 39 40 88 89 I-lower_bound
if 41 43 90 92 O
suspension 44 54 93 103 O
is 55 57 104 106 O
not 58 61 107 110 O
available 62 71 111 120 O

Close 0 5 121 126 O
proximity 6 15 127 136 O
in 16 18 137 139 O
time 19 23 140 144 O
to 24 26 145 147 O
treatment 27 36 148 157 O
with 37 41 158 162 O
high 42 46 163 167 B-treatment
- 46 47 167 168 I-treatment
dose 47 51 168 172 I-treatment
chemotherapy 52 64 173 185 I-treatment
, 64 65 185 186 O
stem 66 70 187 191 B-treatment
- 70 71 191 192 I-treatment
cell 71 75 192 196 I-treatment
rescue 76 82 197 203 I-treatment
, 82 83 203 204 O
differentiation 84 99 205 220 B-treatment
therapy 100 107 221 228 I-treatment
, 107 108 228 229 O
immunotherapy 109 122 230 243 B-treatment
, 122 123 243 244 O
thoracic 124 132 245 253 B-treatment
or 133 135 254 256 I-treatment
mediastinal 136 147 257 268 I-treatment
radiotherapy 148 160 269 281 I-treatment
, 160 161 281 282 O
hormonal 162 170 283 291 B-treatment
therapy 171 178 292 299 I-treatment
, 178 179 299 300 O
biologic 180 188 301 309 B-treatment
therapy 189 196 310 317 I-treatment
, 196 197 317 318 O
herbal 198 204 319 325 B-treatment
cancer 205 211 326 332 I-treatment
therapy 212 219 333 340 I-treatment
, 219 220 340 341 O
hematopoietic 221 234 342 355 O
growth 235 241 356 362 O
factor 242 248 363 369 O
, 248 249 369 370 O
investigational 250 265 371 386 B-treatment
therapy 266 273 387 394 I-treatment
, 273 274 394 395 O
or 275 277 396 398 O
St. 278 281 399 402 B-treatment
John 282 286 403 407 I-treatment
's 286 288 407 409 I-treatment
wort 289 293 410 414 I-treatment
according 294 303 415 424 O
to 304 306 425 427 O
protocol 307 315 428 436 O
- 315 316 436 437 O
defined 316 323 437 444 O
criteria 324 332 445 453 O
prior 333 338 454 459 O
to 339 341 460 462 O
initiation 342 352 463 473 O
of 353 355 474 476 O
study 356 361 477 482 O
drug 362 366 483 487 O

History 0 7 488 495 O
of 8 10 496 498 O
Grade 11 16 499 504 O
> 17 18 505 506 O
= 18 19 506 507 O
2 20 21 508 509 B-lower_bound
central 22 29 510 517 B-chronic_disease
nervous 30 37 518 525 I-chronic_disease
system 38 44 526 532 I-chronic_disease
( 45 46 533 534 I-chronic_disease
CNS 46 49 534 537 I-chronic_disease
) 49 50 537 538 I-chronic_disease
hemorrhage 51 61 539 549 I-chronic_disease

History 0 7 550 557 O
or 8 10 558 560 O
evidence 11 19 561 569 O
of 20 22 570 572 O
retinal 23 30 573 580 O
pathology 31 40 581 590 O
according 41 50 591 600 O
to 51 53 601 603 O
protocol 54 62 604 612 O
- 62 63 612 613 O
defined 63 70 613 620 O
criteria 71 79 621 629 O
, 79 80 629 630 O
including 81 90 631 640 O
serous 91 97 641 647 B-chronic_disease
retinopathy 98 109 648 659 I-chronic_disease

Impaired 0 8 660 668 B-chronic_disease
gastrointestinal 9 25 669 685 I-chronic_disease
absorption 26 36 686 696 I-chronic_disease

Known 0 5 697 702 O
active 6 12 703 709 B-chronic_disease
infection 13 22 710 719 I-chronic_disease
( 23 24 720 721 O
excluding 24 33 721 730 O
fungal 34 40 731 737 B-chronic_disease
infection 41 50 738 747 I-chronic_disease
of 51 53 748 750 I-chronic_disease
the 54 57 751 754 I-chronic_disease
nail 58 62 755 759 I-chronic_disease
beds 63 67 760 764 I-chronic_disease
) 67 68 764 765 O
within 69 75 766 772 O
28 76 78 773 775 B-upper_bound
days 79 83 776 780 I-upper_bound
prior 84 89 781 786 I-upper_bound
to 90 92 787 789 O
initiation 93 103 790 800 O
of 104 106 801 803 O
study 107 112 804 809 O
drug 113 117 810 814 O
that 118 122 815 819 O
has 123 126 820 823 O
not 127 130 824 827 O
completely 131 141 828 838 O
resolved 142 150 839 847 O

Lansky 0 6 848 854 B-clinical_variable
performance 7 18 855 866 I-clinical_variable
status 19 25 867 873 I-clinical_variable
or 26 28 874 876 O
Karnofsky 29 38 877 886 B-clinical_variable
performance 39 50 887 898 I-clinical_variable
status 51 57 899 905 I-clinical_variable
of 58 60 906 908 O
> 61 62 909 910 O
= 62 63 910 911 O
50 64 66 912 914 B-lower_bound
percent 67 74 915 922 I-lower_bound

Life 0 4 923 927 B-clinical_variable
expectancy 5 15 928 938 I-clinical_variable
> 16 17 939 940 O
= 17 18 940 941 O
3 19 20 942 943 B-lower_bound
months 21 27 944 950 I-lower_bound

Major 0 5 951 956 O
surgical 6 14 957 965 O
procedure 15 24 966 975 O
or 25 27 976 978 O
significant 28 39 979 990 O
traumatic 40 49 991 1000 O
injury 50 56 1001 1007 O
within 57 63 1008 1014 O
4 64 65 1015 1016 B-upper_bound
weeks 66 71 1017 1022 I-upper_bound
prior 72 77 1023 1028 I-upper_bound
to 78 80 1029 1031 O
initiation 81 91 1032 1042 O
of 92 94 1043 1045 O
study 95 100 1046 1051 O
drug 101 105 1052 1056 O
, 105 106 1056 1057 O
or 107 109 1058 1060 O
anticipation 110 122 1061 1073 O
of 123 125 1074 1076 O
need 126 130 1077 1081 O
for 131 134 1082 1085 O
major 135 140 1086 1091 O
surgical 141 149 1092 1100 O
procedure 150 159 1101 1110 O
during 160 166 1111 1117 O
the 167 170 1118 1121 O
course 171 177 1122 1128 O
of 178 180 1129 1131 O
the 181 184 1132 1135 O
study 185 190 1136 1141 O

Measurable 0 10 1142 1152 O
disease 11 18 1153 1160 O
as 19 21 1161 1163 O
defined 22 29 1164 1171 O
by 30 32 1172 1174 O
mINRC 33 38 1175 1180 O
, 38 39 1180 1181 O
RANO 40 44 1182 1186 O
criteria 45 53 1187 1195 O
for 54 57 1196 1199 O
HGG 58 61 1200 1203 O
, 61 62 1203 1204 O
RANO 63 67 1205 1209 O
criteria 68 76 1210 1218 O
for 77 80 1219 1222 O
LGG 81 84 1223 1226 O
, 84 85 1226 1227 O
RECIST 86 92 1228 1234 O
v1.1 93 97 1235 1239 O
, 97 98 1239 1240 O
or 99 101 1241 1243 O
evaluable 102 111 1244 1253 O
by 112 114 1254 1256 O
nuclear 115 122 1257 1264 B-treatment
medicine 123 131 1265 1273 I-treatment
techniques 132 142 1274 1284 I-treatment
, 142 143 1284 1285 O
immunocytochemistry 144 163 1286 1305 B-treatment
, 163 164 1305 1306 O
tumor 165 170 1307 1312 B-treatment
markers 171 178 1313 1320 I-treatment
, 178 179 1320 1321 O
or 180 182 1322 1324 O
other 183 188 1325 1330 O
reliable 189 197 1331 1339 O
measures 198 206 1340 1348 O

Participants 0 12 1349 1361 O
< 13 14 1362 1363 O
1 14 15 1363 1364 O
year 16 20 1365 1369 O
of 21 23 1370 1372 O
age 24 27 1373 1376 B-age
will 28 32 1377 1381 O
not 33 36 1382 1385 O
be 37 39 1386 1388 O
enrolled 40 48 1389 1397 O
until 49 54 1398 1403 O
> 55 56 1404 1405 O
= 56 57 1405 1406 O
6 58 59 1407 1408 B-lower_bound
participants 60 72 1409 1421 O
> 73 74 1422 1423 O
= 74 75 1423 1424 O
1 76 77 1425 1426 O
year 78 82 1427 1431 O
to 83 85 1432 1434 O
< 86 87 1435 1436 O
18 88 90 1437 1439 B-upper_bound
years 91 96 1440 1445 I-upper_bound
of 97 99 1446 1448 O
age 100 103 1449 1452 O
have 104 108 1453 1457 O
received 109 117 1458 1466 O
at 118 120 1467 1469 O
least 121 126 1470 1475 O
one 127 130 1476 1479 B-lower_bound
cycle 131 136 1480 1485 O
of 137 139 1486 1488 O
therapy 140 147 1489 1496 B-treatment
with 148 152 1497 1501 O
suspension 153 163 1502 1512 O
and 164 167 1513 1516 O
until 168 173 1517 1522 O
safety 174 180 1523 1529 O
and 181 184 1530 1533 O
pharmacokinetic 185 200 1534 1549 B-treatment
assessment 201 211 1550 1560 I-treatment
of 212 214 1561 1563 O
these 215 220 1564 1569 O
participants 221 233 1570 1582 O
have 234 238 1583 1587 O
been 239 243 1588 1592 O
conducted 244 253 1593 1602 O

Participants 0 12 1603 1615 O
> 13 14 1616 1617 O
= 14 15 1617 1618 O
6 16 17 1619 1620 B-lower_bound
months 18 24 1621 1627 I-lower_bound
to 25 27 1628 1630 O
< 28 29 1631 1632 O
1 30 31 1633 1634 O
year 32 36 1635 1639 O
of 37 39 1640 1642 O
age 40 43 1643 1646 B-age
may 44 47 1647 1650 O
not 48 51 1651 1654 O
be 52 54 1655 1657 O
enrolled 55 63 1658 1666 O
until 64 69 1667 1672 O
> 70 71 1673 1674 O
= 71 72 1674 1675 O
6 73 74 1676 1677 O
participants 75 87 1678 1690 O
> 88 89 1691 1692 O
= 89 90 1692 1693 O
1 91 92 1694 1695 O
year 93 97 1696 1700 O
to 98 100 1701 1703 O
< 101 102 1704 1705 O
18 103 105 1706 1708 B-upper_bound
years 106 111 1709 1714 I-upper_bound
of 112 114 1715 1717 O
age 115 118 1718 1721 O
have 119 123 1722 1726 O
received 124 132 1727 1735 O
at 133 135 1736 1738 O
least 136 141 1739 1744 O
one 142 145 1745 1748 O
cycle 146 151 1749 1754 O
of 152 154 1755 1757 O
therapy 155 162 1758 1765 B-treatment
with 163 167 1766 1770 O
suspension 168 178 1771 1781 O
in 179 181 1782 1784 O
the 182 185 1785 1788 O
dose 186 190 1789 1793 O
- 190 191 1793 1794 O
escalation 191 201 1794 1804 O
phase 202 207 1805 1810 O
and 208 211 1811 1814 O
until 212 217 1815 1820 O
safety 218 224 1821 1827 O
and 225 228 1828 1831 O
pharmacokinetic 229 244 1832 1847 O
assessment 245 255 1848 1858 O
of 256 258 1859 1861 O
these 259 264 1862 1867 O
participants 265 277 1868 1880 O
have 278 282 1881 1885 O
been 283 287 1886 1890 O
conducted 288 297 1891 1900 O

Pregnant 0 8 1901 1909 B-pregnancy

Prior 0 5 1910 1915 B-treatment
allogenic 6 15 1916 1925 I-treatment
bone 16 20 1926 1930 I-treatment
marrow 21 27 1931 1937 I-treatment
transplantation 28 43 1938 1953 I-treatment
or 44 46 1954 1956 O
prior 47 52 1957 1962 B-treatment
solid 53 58 1963 1968 I-treatment
organ 59 64 1969 1974 I-treatment
transplantation 65 80 1975 1990 I-treatment

Tumor 0 5 1991 1996 B-cancer
for 6 9 1997 2000 O
which 10 15 2001 2006 O
prior 16 21 2007 2012 B-treatment
treatment 22 31 2013 2022 I-treatment
has 32 35 2023 2026 O
proven 36 42 2027 2033 O
to 43 45 2034 2036 O
be 46 48 2037 2039 O
ineffective 49 60 2040 2051 O
or 61 63 2052 2054 O
intolerable 64 75 2055 2066 O
or 76 78 2067 2069 O
for 79 82 2070 2073 O
which 83 88 2074 2079 O
no 89 91 2080 2082 O
standard 92 100 2083 2091 B-treatment
therapy 101 108 2092 2099 I-treatment
exists 109 115 2100 2106 O

Tumor 0 5 2107 2112 B-cancer
with 6 10 2113 2117 O
known 11 16 2118 2123 O
or 17 19 2124 2126 O
expected 20 28 2127 2135 O
RAS 29 32 2136 2139 O
/ 32 33 2139 2140 O
RAF 33 36 2140 2143 O
/ 36 37 2143 2144 O
MEK 37 40 2144 2147 O
/ 40 41 2147 2148 O
ERK 41 44 2148 2151 O
pathway 45 52 2152 2159 O
involvement 53 64 2160 2171 O

age 0 3 2172 2175 B-age
at 4 6 2176 2178 O
study 7 12 2179 2184 O
entry 13 18 2185 2190 O
> 19 20 2191 2192 O
= 20 21 2192 2193 O
6 22 23 2194 2195 B-lower_bound
months 24 30 2196 2202 I-lower_bound
to 31 33 2203 2205 O
< 34 35 2206 2207 O
18 36 38 2208 2210 B-upper_bound
years 39 44 2211 2216 I-upper_bound

age 0 3 2217 2220 B-age
at 4 6 2221 2223 O
study 7 12 2224 2229 O
entry 13 18 2230 2235 O
> 19 20 2236 2237 O
= 20 21 2237 2238 O
6 22 23 2239 2240 B-lower_bound
years 24 29 2241 2246 I-lower_bound
to 30 32 2247 2249 O
< 33 34 2250 2251 O
18 35 37 2252 2254 B-upper_bound
years 38 43 2255 2260 I-upper_bound

age 0 3 2261 2264 B-age
at 4 6 2265 2267 O
study 7 12 2268 2273 O
entry 13 18 2274 2279 O
to 19 21 2280 2282 O
be 22 24 2283 2285 O
> 25 26 2286 2287 O
= 26 27 2287 2288 O
6 28 29 2289 2290 B-lower_bound
months 30 36 2291 2297 I-lower_bound
( 37 38 2298 2299 O
> 38 39 2299 2300 O
= 39 40 2300 2301 O
6 40 41 2301 2302 B-lower_bound
years 42 47 2303 2308 I-lower_bound
if 48 50 2309 2311 O
suspension 51 61 2312 2322 O
is 62 64 2323 2325 O
not 65 68 2326 2329 O
available 69 78 2330 2339 O
) 78 79 2339 2340 O
to 80 82 2341 2343 O
< 83 84 2344 2345 O
30 85 87 2346 2348 B-upper_bound
years 88 93 2349 2354 I-upper_bound

lactating 0 9 2355 2364 O
women 10 15 2365 2370 B-gender

